37. Generalised pustular psoriasis Clinical trials / Disease details
Clinical trials : 79 / Drugs : 57 - (DrugBank : 21) / Drug target genes : 20 - Drug target pathways : 102
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01091051 (ClinicalTrials.gov) | March 2010 | 18/3/2010 | Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis | Safety and Efficacy of Ustekinumab in the Treatment of Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis | Palmo-Plantar Pustular Psoriasis;Palmo-Plantar Pustulosis | Drug: Ustekinumab;Drug: Placebo (Soduim Chloride) | Innovaderm Research Inc. | Janssen-Ortho LLC | Terminated | 18 Years | N/A | Both | 33 | Phase 3 | Canada |